<DOC>
	<DOC>NCT02626871</DOC>
	<brief_summary>The primary purpose of the FIN-bioAVR registry is to assess the incidence of AF, strokes and major bleeding events in patients undergoing aortic valve replacement. This retrospective multicenter registry will include 850 patients with aortic valve replacement using bioprosthesis.</brief_summary>
	<brief_title>Atrial Fibrillation, Stroke, and Bleeding in Patients Undergoing Aortic Biovalve Implantation</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<mesh_term>Ischemic Attack, Transient</mesh_term>
	<criteria>patients undergoing aortic valve bioprosthesis implantation mechanical heart valves in any position</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>